Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
In-silico evaluation of BCHE-targeting compounds with potential relevance to mild cognitive impairment and Alzheimer’s disease
View through CrossRef
Abstract
Background
The cholinergic neurotransmitter is predominant in the brain. Butyrylcholinesterase (BCHE) is one of the cholinesterases present in the brain. Inhibition of the BCHE could regulate the choline level within the brain, therefore regulating the occurrence of Alzheimer's disease (AD) or mild cognitive impairment (MCI).
Research design and methods:
In the present study, we tried to find out the potential inhibitor for BCHE. YASARA molecular docking analysis and MD simulation study were performed for the screening of cholinesterase inhibitor drugs (as a potential ligand). The present study involves, docking interaction study of the seventeen ligands with BCHE (retrieved from the Protein Data Bank).
Result
YASARA docking tool study and further MD simulation showed that of the seventeen drugs, Donepezil, Huperzine, Galantamine, Tacrine, and Carbofuran have maximum positive-score-binding interaction on the prominent binding site of BCHE.
Conclusion
YASARA docking analysis and MD simulation provide us with some potential therapeutic drugs as Donepezil, Huperzine, Galantamine, Tacrine and Carbofuran, for the inhibition of the BCHE in MCI.
Title: In-silico evaluation of BCHE-targeting compounds with potential relevance to mild cognitive impairment and Alzheimer’s disease
Description:
Abstract
Background
The cholinergic neurotransmitter is predominant in the brain.
Butyrylcholinesterase (BCHE) is one of the cholinesterases present in the brain.
Inhibition of the BCHE could regulate the choline level within the brain, therefore regulating the occurrence of Alzheimer's disease (AD) or mild cognitive impairment (MCI).
Research design and methods:
In the present study, we tried to find out the potential inhibitor for BCHE.
YASARA molecular docking analysis and MD simulation study were performed for the screening of cholinesterase inhibitor drugs (as a potential ligand).
The present study involves, docking interaction study of the seventeen ligands with BCHE (retrieved from the Protein Data Bank).
Result
YASARA docking tool study and further MD simulation showed that of the seventeen drugs, Donepezil, Huperzine, Galantamine, Tacrine, and Carbofuran have maximum positive-score-binding interaction on the prominent binding site of BCHE.
Conclusion
YASARA docking analysis and MD simulation provide us with some potential therapeutic drugs as Donepezil, Huperzine, Galantamine, Tacrine and Carbofuran, for the inhibition of the BCHE in MCI.
Related Results
Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities
Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities
<b><i>Introduction:</i></b> Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are two cholinergic enzymes catalyzing the reaction of cleaving ace...
Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer’s Disease—Could BCHE Genotyping Be Helpful in Alzheimer’s Therapy?
Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer’s Disease—Could BCHE Genotyping Be Helpful in Alzheimer’s Therapy?
Late-onset Alzheimer’s disease (AD) is clinically characterized by a progressive decline of memory and other cognitive functions leading to the loss of the ability to perform every...
Leveraging speech and artificial intelligence to screen for early Alzheimer’s disease and amyloid beta positivity
Leveraging speech and artificial intelligence to screen for early Alzheimer’s disease and amyloid beta positivity
Abstract
Early detection of Alzheimer’s disease is required to identify patients suitable for disease-modifying medications and to improve access to non-pharmacologi...
Molecular imaging of butyrylcholinesterase associated with amyloid-β plaques distinguishes 5XFAD from wild-type mice
Molecular imaging of butyrylcholinesterase associated with amyloid-β plaques distinguishes 5XFAD from wild-type mice
Abstract
Purpose
Diagnosis of Alzheimer’s disease (AD) requires symptoms of dementia and accumulation of amyloid-β (Aβ) and tau...
Structure‐Based Design of Chiral Thioureas as Anticholinesterase Inhibitors Using Enantiopure α‐Methylbenzylamines: Synthesis, Enzyme Inhibition, and In Silico Studies
Structure‐Based Design of Chiral Thioureas as Anticholinesterase Inhibitors Using Enantiopure α‐Methylbenzylamines: Synthesis, Enzyme Inhibition, and In Silico Studies
ABSTRACT
A detailed analysis of the research on the treatment of Alzheimer's disease indicates that selective inhibition of butyrylcholineste...
Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Abstract— Alzheimer's disease is a neurodegenerative disease that develops gradually, and is associated with cardiovascular and cerebrovascular problems. Alzheimer's is a serious d...
Ketogenic interventions in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease: A systematic review and critical appraisal
Ketogenic interventions in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease: A systematic review and critical appraisal
BackgroundThere is increasing interest in therapeutic ketosis as a potential therapy for neurodegenerative disorders–in particular, mild cognitive impairment (MCI), Alzheimer's dis...
Clinical characteristics and biomarker profile in early- and late-onset Alzheimer’s disease: the Shanghai Memory Study
Clinical characteristics and biomarker profile in early- and late-onset Alzheimer’s disease: the Shanghai Memory Study
Abstract
Early-onset Alzheimer’s disease constitutes ∼5–10% of Alzheimer’s disease. Its clinical characteristics and biomarker profiles are not well documented. To c...